These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 15148101)

  • 1. Elevated serum granulocyte colony-stimulating factor levels in patients with active phase of sweet syndrome and patients with active behcet disease: implication in neutrophil apoptosis dysfunction.
    Kawakami T; Ohashi S; Kawa Y; Takahama H; Ito M; Soma Y; Mizoguchi M
    Arch Dermatol; 2004 May; 140(5):570-4. PubMed ID: 15148101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neutrophil, not the tumor: serum CA 15-3 elevation as a result of granulocyte--colony-stimulating factor-induced neutrophil MU1C overexpression and neutrophilia in patients with breast carcinoma receiving adjuvant chemotherapy.
    Pentheroudakis G; Malamou-Mitsi V; Briasoulis E; Damala K; Vassou A; Vartholomatos G; Kolaitis N; Pavlidis N
    Cancer; 2004 Oct; 101(8):1767-75. PubMed ID: 15386335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
    Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
    Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte and granulocyte-macrophage colony-stimulating factors, their receptors and interleukin-3 levels in newborns.
    Coşkun M; Kardelen F; Oygür N; Undar L; Savaş A; Yeğin O
    Turk J Pediatr; 1997; 39(3):295-301. PubMed ID: 9339107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G-CSF and GM-CSF concentrations and receptor expression in peripheral blood leukemic cells from patients with chronic myelogenous leukemia.
    Lee J; Kim Y; Lim J; Kim M; Han K
    Ann Clin Lab Sci; 2008; 38(4):331-7. PubMed ID: 18988925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in treated patients with chronic myelogenous leukemia in chronic phase.
    Balleari E; Bason C; Visani G; Gobbi M; Ottaviani E; Ghio R
    Haematologica; 1994; 79(1):7-12. PubMed ID: 15378942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum granulocyte colony-stimulating factor levels are not increased in patients with autoimmune neutropenia of infancy.
    Corbacioglu S; Bux J; König A; Gabrilove JL; Welte K; Bussel JB
    J Pediatr; 2000 Jul; 137(1):96-9. PubMed ID: 10891829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The plasma levels of granulocyte-colony stimulating factor and granulocyte-macrophage colony stimulating factor in breast cancer patients].
    Ławicki S; Czygier M; Omyła J; Bedkowska E; Szmitkowski M
    Pol Merkur Lekarski; 2007 Oct; 23(136):259-63. PubMed ID: 18293847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Behçet's disease.
    Buldanlioglu S; Turkmen S; Ayabakan HB; Yenice N; Vardar M; Dogan S; Mercan E
    Br J Dermatol; 2005 Sep; 153(3):526-30. PubMed ID: 16120137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte colony-stimulating factor/granulocyte colony-stimulating factor receptor biological axis promotes survival and growth of bladder cancer cells.
    Chakraborty A; Guha S
    Urology; 2007 Jun; 69(6):1210-5. PubMed ID: 17572226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased serum ferritin levels in active Behçet's disease.
    Odabas AR; Karakuzu A; Cetinkaya R; Selcuk Y; Keles S; Bilen H
    Int J Clin Pract; 2002 May; 56(4):310-1. PubMed ID: 12074217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum granulocyte-colony stimulating factor (G-CSF) levels in elderly patients with infections].
    Kawakami M
    Hokkaido Igaku Zasshi; 1994 Jul; 69(4):847-56. PubMed ID: 7525437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical granulocyte colony-stimulating factor for the treatment of oral and genital ulcers of patients with Behçet's disease.
    Bacanli A; Yerebakan Dicle O; Parmaksizoglu B; Yilmaz E; Alpsoy E
    J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):931-5. PubMed ID: 16922940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of IL-15 in serum and cerebrospinal fluid of patients with Behçet's disease.
    Hamzaoui K; Hamzaoui A; Ghorbel I; Khanfir M; Houman H
    Scand J Immunol; 2006 Dec; 64(6):655-60. PubMed ID: 17083622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous granulocyte colony-stimulating factor (G-CSF) levels in chemotherapy-induced neutropenia and in neutropenia related with primary diseases.
    Kavgaci H; Ozdemir F; Aydin F; Yavuz A; Yavuz M
    J Exp Clin Cancer Res; 2002 Dec; 21(4):475-9. PubMed ID: 12636092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil CD64 expression in Behçet's disease.
    Ureten K; Ertenli I; Oztürk MA; Kiraz S; Onat AM; Tuncer M; Okur H; Akdogan A; Apras S; Calgüneri M
    J Rheumatol; 2005 May; 32(5):849-52. PubMed ID: 15868620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum substance P and calcitonin gene-related peptide levels in Behçet's disease and their association with disease activity.
    Aki T; Karincaoglu Y; Seyhan M; Batcioglu K
    Clin Exp Dermatol; 2006 Jul; 31(4):583-7. PubMed ID: 16716167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine: an activity marker in Behçet's disease?
    Sarican T; Ayabakan H; Turkmen S; Kalaslioglu V; Baran F; Yenice N
    J Dermatol Sci; 2007 Feb; 45(2):121-6. PubMed ID: 17182219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MALDI-TOF/TOF-MS reveals elevated serum haptoglobin and amyloid A in Behcet's disease.
    Mao L; Dong H; Yang P; Zhou H; Huang X; Lin X; Kijlstra A
    J Proteome Res; 2008 Oct; 7(10):4500-7. PubMed ID: 18754684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.